PA
PSI Advisors’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $719K | Sell |
3,872
-230
| -6% | -$42.7K | 0.35% | 38 |
|
|
2025
Q1 | $859K | Buy |
4,102
+267
| +7% | +$55.9K | 0.28% | 50 |
|
|
2024
Q4 | $681K | Buy |
3,835
+1
| +0% | +$178 | 0.2% | 63 |
|
|
2024
Q3 | $757K | Sell |
3,834
-69
| -2% | -$13.6K | 0.22% | 69 |
|
|
2024
Q2 | $669K | Buy |
3,903
+77
| +2% | +$13.2K | 0.21% | 68 |
|
|
2024
Q1 | $697K | Sell |
3,826
-655
| -15% | -$119K | 0.25% | 64 |
|
|
2023
Q4 | $694K | Buy |
4,481
+71
| +2% | +$11K | 0.26% | 69 |
|
|
2023
Q3 | $657K | Buy |
4,410
+231
| +6% | +$34.4K | 0.28% | 63 |
|
|
2023
Q2 | $563K | Sell |
4,179
-427
| -9% | -$57.5K | 0.25% | 70 |
|
|
2023
Q1 | $734K | Buy |
4,606
+193
| +4% | +$30.8K | 0.35% | 55 |
|
|
2022
Q4 | $713K | Sell |
4,413
-12,963
| -75% | -$2.09M | 0.38% | 51 |
|
|
2022
Q3 | $2.33M | Sell |
17,376
-6,264
| -26% | -$841K | 1.23% | 20 |
|
|
2022
Q2 | $3.62M | Sell |
23,640
-2,694
| -10% | -$413K | 1.78% | 11 |
|
|
2022
Q1 | $4.27M | Sell |
26,334
-363
| -1% | -$58.8K | 1.76% | 15 |
|
|
2021
Q4 | $3.62M | Buy |
26,697
+696
| +3% | +$94.2K | 1.47% | 15 |
|
|
2021
Q3 | $2.81M | Buy |
26,001
+2,140
| +9% | +$231K | 1.29% | 20 |
|
|
2021
Q2 | $2.69M | Buy |
23,861
+1,117
| +5% | +$126K | 1.42% | 20 |
|
|
2021
Q1 | $2.46M | Buy |
22,744
+15,621
| +219% | +$1.69M | 1.45% | 19 |
|
|
2020
Q4 | $763K | Buy |
7,123
+4,133
| +138% | +$443K | 0.53% | 42 |
|
|
2020
Q3 | $261K | Buy |
+2,990
| New | +$261K | 0.2% | 94 |
|
|
2020
Q1 | – | Sell |
-558
| Closed | -$49K | – | 109 |
|
|
2019
Q4 | $49K | Buy |
+558
| New | +$49K | 0.03% | 265 |
|